About Idelalisib Idelalisib is a medication used to treat certain blood cancers. Idelalisib acts as a phosphoinositide 3-kinase…
Chidamide (also named Tucidinostat) is a histone deacetylase (HDAC) inhibitor that is used to treat various…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
Golidocitinib (DZD4205) is currently the first and only Janus kinase 1 (JAK1) selective inhibitor being evaluated…
Zuberitamab is an innovative anti-CD20 monoclonal antibody injection. Zuberitamab is a biosimilar of rituximab, a monoclonal…
Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab sold under the brand name…
Linperlisib, a next-generation PI3Kδ-selective oral inhibitor, received marketing approval in China in 2022 for treatment of…
Orelabrutinib is a novel, highly selective, irreversible BTK inhibitor with high target selectivity and safety. Orelabrutinib sold…
Zimberelimab is an anti-programmed cell death protein-1 (PD-1) monoclonal antibody being developed by Gloria Biosciences, Arcus…
About Penpulimab Penpulimab is an IgG1 monoclonal antibody that's designed to eliminate Fcγ receptor binding and…
About Pirtobrutinib Pirtobrutinib is an inhibits B cell lymphocyte proliferation and survival by binding and inhibiting Bruton's tyrosine…
TYVYT® (sintilimab injection) is a fully human IgG4 monoclonal antibody, which specifically binds to PD-1 expressed on…
About Cejemly® (Sugemalimab) The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal…
About Tazemetostat Tazemetostat is a selective inhibitor of EZH2, administered orally.It is approved treatment for Follicular…
ABout Crizotinib Crizotinib is a prescription medicine used to treat people with non-small cell lung cancer…
Tevimbra (Tislelizumab-jsgr) sold under the brand name 百泽安 in china, is a humanized IgG4 anti–PD-1 monoclonal…
Copyright © 2021-2022 LienTeh.net All rights reserved.
